EphA2, which is cleaved in the extracellular region by membrane type 1 matrix metalloproteinase (MT1-MMP) and released extracellularly, is not highly enzymatically active; rather, colon cancer expresses high levels of EphA2 [20,21]. Here, EPHA2 is linked to malignant colon neoplasm.